Vanderbilt-Ingram Cancer Center Archive — Page 6 of 27
-
October 31, 2024
Chic Awearness surpasses $1 million for ovarian cancer research and patient support
Founded by Marci Houff, the event supports ovarian cancer research at Vanderbilt-Ingram Cancer Center and patient support initiatives. -
October 30, 2024
Michael Gibson votes with FDA panel to limit immunotherapy indication
The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival. -
October 15, 2024
Cathy Eng named Vanderbilt-Ingram Cancer Center associate director of Strategic Relations and Research Partnerships
Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies. -
October 7, 2024
New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage
Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients. -
October 7, 2024
VUMC hosts International Lung Cancer Consortium meeting
The consortium is coordinated by the International Agency for Research on Cancer with the aim of sharing data from ongoing lung cancer case-control and cohort studies. -
October 4, 2024
‘Off-the-shelf’ CAR-T therapy shows promise for relapsed/refractory multiple myeloma
The therapy, P-BCMA-ALL01, demonstrated a 91% overall response rate for the 23 patients participating in the phase 1 trial. -
October 3, 2024
DAISY Award spotlight: ‘She has been there so many times for my husband and me.’
Jenny Meier, RN, works in the Vanderbilt-Ingram Cancer Center. She is one of the latest DAISY Award winners at VUMC.